These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34647343)

  • 21. [TDI determination in polyurethane paints and in work environment (author's transl)].
    Scrima M; Salvadori P
    Lav Um; 1976 Mar; 28(2):48-59. PubMed ID: 190498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer incidence and mortality of isocyanate exposed workers from the Swedish polyurethane foam industry: updated findings 1959-98.
    Mikoczy Z; Welinder H; Tinnerberg H; Hagmar L
    Occup Environ Med; 2004 May; 61(5):432-7. PubMed ID: 15090664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of chemical-specific IgG antibodies in male workers from a urethane foam factory.
    Tsuji M; Ishihara Y; Isse T; Koriyama C; Yamamoto M; Kakiuchi N; Yu HS; Tanaka M; Tsuchiya T; Ohta M; Tanaka R; Kawamoto T
    Environ Health Prev Med; 2018 Jun; 23(1):24. PubMed ID: 29921217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diisocyanate emission from a paint product: a preliminary analysis.
    Jarand CW; Akapo SO; Swenson LJ; Kelman BJ
    Appl Occup Environ Hyg; 2002 Jul; 17(7):491-4. PubMed ID: 12083169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Occupational exposure of workers to vapors of p,p'-diphenylmethane diisocyanate used in the production of building materials filled with polyurethane foam].
    Marcinkowski J; Kubiak K
    Med Pr; 1982; 33(1-3):149-52. PubMed ID: 7144537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological monitoring of occupational exposure to toluene diisocyanate.
    Maître A; Berode M; Perdrix A; Romazini S; Savolainen H
    Int Arch Occup Environ Health; 1993; 65(2):97-100. PubMed ID: 8253517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of genetic factors on toluene diisocyanate-related symptoms: evidence from a cross-sectional study.
    Broberg K; Tinnerberg H; Axmon A; Warholm M; Rannug A; Littorin M
    Environ Health; 2008 Apr; 7():15. PubMed ID: 18447907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptoms and lung function in low-exposure to TDI by polyurethane foam manufacturing.
    Alexandersson R; Hedenstierna G; Randma E; Rosen G; Swenson A; Tornling G
    Int Arch Occup Environ Health; 1985; 55(2):149-57. PubMed ID: 2985507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sequential tape monitor for toluene diisocyanate.
    Rando RJ; Duvoisin PF; Abdel-Kader H; Hammad YY
    Am Ind Hyg Assoc J; 1987 Jun; 48(6):574-9. PubMed ID: 3039820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study on the immunologic effects in workers exposed to low levels of toluene-diisocyanate (TDI)].
    Taniwaki H; Shima S; Tachikawa S; Kato Y; Yoshida T; Ito T; Nagaoka K; Yuri T; Hosoda H; Miki T
    Sangyo Igaku; 1987 Mar; 29(2):130-5. PubMed ID: 3041074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four-year follow-up of effects of toluene diisocyanate exposure on the respiratory system in polyurethane foam manufacturing workers. I. Study design and results of the first cross-sectional observation.
    Omae K; Nakadate T; Higashi T; Nakaza M; Aizawa Y; Sakurai H
    Int Arch Occup Environ Health; 1992; 63(8):559-64. PubMed ID: 1316879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of exposure to TDI and MDI during polyurethane foam production in Poland using integrated theoretical and experimental data.
    Kupczewska-Dobecka M; Czerczak S; Brzeźnicki S
    Environ Toxicol Pharmacol; 2012 Sep; 34(2):512-518. PubMed ID: 22809748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toluene diisocyanate concentration investigation among TDI-related factories in Taiwan and their relations to the type of industry.
    Yeh HJ; Shih TS; Tsai PJ; Chang HY
    J Expo Anal Environ Epidemiol; 2002 Mar; 12(2):157-64. PubMed ID: 11965532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community exposure to toluene diisocyanate from a polyurethane foam manufacturing plant--North Carolina, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Jun; 47(22):455-7. PubMed ID: 9639366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toluene diisocyanate.
    Peters JM; Wegman DH
    Lancet; 1978 Aug; 2(8087):472. PubMed ID: 79829
    [No Abstract]   [Full Text] [Related]  

  • 36. Toluene diisocyanate.
    Burge PS; Taylor AJ; Harries MG; O'Brien I
    Lancet; 1978 Jul; 2(8080):96-7. PubMed ID: 78315
    [No Abstract]   [Full Text] [Related]  

  • 37. Air exposure assessment of TDI and biological monitoring of TDA in urine in workers in polyurethane foam industry.
    Geens T; Dugardin S; Schockaert A; De Cooman G; van Sprundel M
    Occup Environ Med; 2012 Feb; 69(2):93-8. PubMed ID: 21725071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toluene diisocyanate.
    Adams WG; Carney IF; Chamberlain JD; Paddle GM
    Lancet; 1978 Jun; 1(8077):1308. PubMed ID: 78066
    [No Abstract]   [Full Text] [Related]  

  • 39. Occupational asthma due to toluene diisocyanate among velcro-like tape manufacturers.
    Wang JD; Huang PH; Lin JM; Su SY; Wu MC
    Am J Ind Med; 1988; 14(1):73-8. PubMed ID: 2841849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory effects in toluene diisocyanate manufacture: a multidisciplinary approach.
    Weill H; Salvaggio J; Neilson A; Butcher B; Ziskind M
    Environ Health Perspect; 1975 Jun; 11():101-8. PubMed ID: 170075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.